Premium
Discussion of “A Hybrid Phase I‐II/III Clinical Trial Design Allowing Dose Re‐Optimization in Phase III” by Andrew G. Chapple and Peter F. Thall
Author(s) -
Leifer Eric S.,
Geller Nancy L.
Publication year - 2019
Publication title -
biometrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.298
H-Index - 130
eISSN - 1541-0420
pISSN - 0006-341X
DOI - 10.1111/biom.12993
Subject(s) - biostatistics , medicine , library science , gerontology , epidemiology , computer science